Homatropine Methylbromide and Hydrocodone Bitartrate Syrup — FDA Drug Shortage
The FDA lists a drug shortage record for Homatropine Methylbromide and Hydrocodone Bitartrate Syrup (syrup) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 09/11/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0472-1030-16
- Dosage Form
- Syrup
- Presentation
- Hydromet, Syrup, 1.5 mg/5 mL; 5 mg/5 mL (NDC 0472-1030-16)
- Initial Posting
- 09/11/2025
- Revised Date